Cronos Group Inc (CRON)
Fair Value-7.6% Downside
Fair
Analyst-27.3% Downside
Market Cap1.262 B
P/E18.0x
Yield0.0%
HealthExcellent
NASDAQ
Featured in
High-Growth Small-Cap Stocks
Enveric Biosciences Inc (ENVB)
Fair Value36.6% Upside
Undervalued
Market Cap6.893 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Evolus Inc (EOLS)
Fair Value8.6% Upside
Fair
Analyst81.8% Upside
Market Cap544.9 M
P/E—
Yield0.0%
HealthGood
NASDAQ
HUTCHMED DRC (HCM)
Fair Value13.7% Upside
Fair
Analyst56.4% Upside
Market Cap2.482 B
P/E138.8x
Yield0.0%
HealthGood
NASDAQ
Hyperion DeFi Inc (HYPD)
Fair Value0.2% Upside
Fair
Analyst146.2% Upside
Market Cap62.002 M
P/E—
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Beta Momentum
Jaguar Health Inc (JAGX)
Fair Value-88.2% Downside
Expensive
Market Cap11.873 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Kiora Pharmaceuticals Inc (KPRX)
Fair Value-14.2% Downside
Fair
Analyst342.8% Upside
Market Cap17.244 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Lexaria Bioscience Corp (LEXX)
Fair Value48.8% Upside
Undervalued
Market Cap5.321 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
NRX Pharmaceuticals Inc (NRXP)
Fair Value1.9% Upside
Fair
Market Cap143.6 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Purple Biotech (PPBT)
Fair Value89.4% Upside
Bargain
Market Cap10.779 M
P/E—
Yield0.0%
HealthFair
NASDAQ
SenesTech Inc (SNES)
Fair Value45.9% Upside
Undervalued
Analyst764.3% Upside
Market Cap4.236 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Sol Gel Technologies Ltd (SLGL)
Fair Value-21.0% Downside
Overvalued
Analyst150.2% Upside
Market Cap199.6 M
P/E—
Yield0.0%
HealthFair
NASDAQ
TherapeuticsMD Inc (TXMD)
Fair Value-14.8% Downside
Fair
Market Cap25.001 M
P/E—
Yield0.0%
HealthGood
NASDAQ
Wave Life Sciences Ltd (WVE)
Fair Value32.2% Upside
Undervalued
Analyst326.0% Upside
Market Cap857.2 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Zevra Therapeutics Inc (ZVRA)
Fair Value11.8% Upside
Fair
Analyst115.9% Upside
Market Cap687.7 M
P/E12.1x
Yield0.0%
HealthExcellent
NASDAQ
Featured in
Financially Strong Value
High-Growth Small-Cap Stocks
Addex Therapeutics Ltd (ADXN)
Fair Value41.7% Upside
Undervalued
Market Cap3.316 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Aquestive Therapeutics Inc (AQST)
Fair Value0.3% Upside
Fair
Analyst88.6% Upside
Market Cap621.3 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Artelo Biosciences Inc (ARTL)
Fair Value11.7% Upside
Fair
Market Cap2.273 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Arvinas Inc (ARVN)
Fair Value22.4% Upside
Undervalued
Analyst63.7% Upside
Market Cap556.4 M
P/E59.8x
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Growth Small-Cap Stocks
Atea Pharmaceuticals Inc (AVIR)
Fair Value-4.4% Downside
Fair
Analyst67.0% Upside
Market Cap452.4 M
P/E—
Yield0.0%
HealthFair
NASDAQ
BGM Group Ltd (BGM)
Fair Value23.3% Upside
Undervalued
Market Cap103.3 M
P/E—
Yield0.0%
HealthFair
NASDAQ
CalciMedica Inc (CALC)
Fair Value18.2% Upside
Undervalued
Market Cap12.769 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Cardiol Therapeutics Inc Class A (CRDL)
Fair Value-14.8% Downside
Fair
Analyst344.2% Upside
Market Cap221.8 M
P/E—
Yield0.0%
HealthFair
NASDAQ
China SXT Pharmaceuticals Inc (SXTC)
Fair Value40.5% Upside
Undervalued
Market Cap3.264 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Cns Pharmaceuticals Inc (CNSP)
Fair Value53.7% Upside
Bargain
Analyst90.9% Upside
Market Cap7.657 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Context Therapeutics Inc (CNTX)
Fair Value12.2% Upside
Fair
Analyst992.8% Upside
Market Cap35.75 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Cybin Inc (HELP)
Fair Value-20.2% Downside
Overvalued
Analyst193.4% Upside
Market Cap1.002 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Momentum Stocks
High-Beta Momentum
Definium Therapeutics Inc (DFTX)
Fair Value-5.3% Downside
Fair
Analyst77.7% Upside
Market Cap5.418 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Momentum Stocks
Edgewise Therapeutics Inc (EWTX)
Fair Value-16.1% Downside
Fair
Analyst18.2% Upside
Market Cap4.834 B
P/E—
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Momentum Stocks
Enliven Therapeutics Inc (ELVN)
Fair Value-42.1% Downside
Overvalued
Analyst53.4% Upside
Market Cap3.531 B
P/E—
Yield0.0%
HealthGood
NASDAQ
Eton Pharmaceuticals Inc (ETON)
Fair Value-7.4% Downside
Fair
Analyst24.4% Upside
Market Cap1.632 B
P/E128.6x
Yield0.0%
HealthGreat
NASDAQ
Featured in
High-Growth Small-Cap Stocks
Fulcrum Therapeutics Inc (FULC)
Fair Value24.4% Upside
Undervalued
Analyst-4.5% Downside
Market Cap293 M
P/E—
Yield0.0%
HealthFair
NASDAQ
GH Research PLC (GHRS)
Fair Value-19.3% Downside
Overvalued
Analyst53.9% Upside
Market Cap1.912 B
P/E—
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Momentum Stocks
High-Beta Momentum
Harmony Biosciences Holdings (HRMY)
Fair Value48.7% Upside
Undervalued
Analyst14.0% Upside
Market Cap2.419 B
P/E13.5x
Yield0.0%
HealthExcellent
NASDAQ
High Tide Inc (HITI)
Fair Value10.6% Upside
Fair
Analyst69.1% Upside
Market Cap245.9 M
P/E—
Yield0.0%
HealthGreat
NASDAQ
IM Cannabis Corp (IMCC)
Fair Value-35.3% Downside
Overvalued
Market Cap2.562 M
P/E—
Yield0.0%
HealthFair
NASDAQ
ImageneBio Inc (IMA)
Fair Value21.7% Upside
Undervalued
Analyst271.1% Upside
Market Cap55.055 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
InMed Pharmaceuticals Inc (INM)
Fair Value6.0% Upside
Fair
Market Cap9.235 M
P/E—
Yield0.0%
HealthFair
NASDAQ
LENZ Therapeutics Inc (LENZ)
Fair Value49.1% Upside
Undervalued
Analyst481.1% Upside
Market Cap129.8 M
P/E—
Yield0.0%
HealthFair
NASDAQ
LeonaBio Inc (LONA)
Fair Value14.3% Upside
Fair
Analyst186.5% Upside
Market Cap59.639 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Liquidia Technologies Inc (LQDA)
Fair Value22.2% Upside
Undervalued
Analyst57.0% Upside
Market Cap6.144 B
P/E44.3x
Yield0.0%
HealthGreat
NASDAQ
Milestone Pharmaceuticals Inc (MIST)
Fair Value-2.2% Downside
Fair
Analyst536.0% Upside
Market Cap129.8 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Nutriband Inc (NTRB)
Fair Value51.3% Upside
Bargain
Analyst121.9% Upside
Market Cap82.172 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Momentum Stocks
Bullish Trend Stocks
Oculis Holding AG (OCS)
Fair Value-15.9% Downside
Fair
Analyst245.1% Upside
Market Cap661.2 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
OrganiGram Holdings Inc (OGI)
Fair Value14.3% Upside
Fair
Market Cap157.4 M
P/E2.6x
Yield0.0%
HealthGreat
NASDAQ
Pharvaris NV (PHVS)
Fair Value13.3% Upside
Fair
Analyst65.4% Upside
Market Cap2.471 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Phathom Pharmaceuticals Inc (PHAT)
Fair Value-6.6% Downside
Fair
Analyst163.6% Upside
Market Cap616.4 M
P/E—
Yield0.0%
HealthFair
NASDAQ